| |
| |
|
| Insider
Information: |
Machiels Alec |
| Relationship: |
Director |
| City: |
Greenwood Village |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
377,113 |
|
|
Indirect Shares
|
411,950 |
|
|
| Direct
Value |
$15,275,353 |
|
|
|
Indirect Value
|
$16,972,340 |
|
|
| Total
Shares |
789,063 |
|
|
| Total
Value |
$32,247,693 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Director |
2024-01-01 |
370,761 |
2024-01-01 |
411,950 |
Premium* |
|
|
Creative Realities Inc |
CREX |
Director |
2019-10-01 |
6,352 |
2019-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2018-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
930 |
930 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2017-11-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,020 |
|
- |
|
| CREX |
Creative Realities Inc |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,718 |
2,718 |
0 |
- |
|
| CREX |
Creative Realities Inc |
Director |
– • – |
2019-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,634 |
6,352 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-03-15 |
4 |
AS |
$39.57 |
$49,463 |
D/D |
(1,250) |
259,544 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-03-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
260,794 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-04-14 |
4 |
AS |
$50.90 |
$63,625 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-05-16 |
4 |
AS |
$39.18 |
$48,975 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-06-15 |
4 |
AS |
$39.29 |
$49,113 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-07-15 |
4 |
AS |
$46.33 |
$57,913 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-15 |
4 |
AS |
$67.21 |
$84,013 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-09-15 |
4 |
AS |
$66.00 |
$82,500 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-10-14 |
4 |
AS |
$59.31 |
$74,138 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-11-15 |
4 |
AS |
$48.01 |
$60,013 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-12-15 |
4 |
AS |
$52.35 |
$65,438 |
D/D |
(1,250) |
263,774 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-04-14 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-05-16 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-06-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-07-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-08-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-09-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-10-14 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2022-11-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-12-15 |
4 |
OE |
$2.67 |
$3,338 |
D/D |
1,250 |
265,024 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2023-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,867 |
267,641 |
0 |
- |
|
96 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
